Novo Nordisk identifies unauthorised data access from trials

Novo Nordisk has identified that certain patient data from some of its clinical trials was accessed and copied externally in an unauthorised manner following a recent cyberattack on its internal IT systems. Novo Nordisk said the breach involved a limited amount of information relating to patients enrolled in certain clinical trials. Novo Nordisk said the data is not linked to names or identifiers and does not allow participant identification. Credit: Kittyfly / Shutterstock.com. Novo Nordisk has identified that certain patient information from some of its clinical trials was accessed and copied externally in an unauthorised manner following a recent cyberattack…

Source: Clinical Trials Arena